UCL-TB scientists in tri-disciplinary visit to Seoul

18 December 2019

UCL-TB scientists recently visited their counterparts in Seoul, Republic of Korea to develop tri-disciplinary research collaborations on tuberculosis that included microbiology, immunology and pharmacology.

From our side, Frank Kloprogge from the Institute for Global Health had worked with Ju Sang Kim of the Catholic University of Korea, and Korean colleagues, to obtain funding through an MRC-KHIDI partnering programme that was awarded in 2019. “There are a lot of 2-way collaborations”, Frank said, “But you really need all three disciplines working together”.

Frank was accompanied by Hanif Esmail from the UCL MRC Clinical Trials Unit and Institute for Global Health, and Priya Solanki from the UCL Centre for Clinical Microbiology. The Korean partners were also representing Inje University and the Korea National Institute of Health.

Discussions were held to identify possibilities for collaboration through development of patient cohorts, as well as building capacity and harmonising procedures and analysis methods. This trip will be followed by a reciprocal visit to London next Spring.

Hanif Esmail (6th from left) presents in a meeting with Frank Kloprogge (left), Priya Solanki (4th from left), to Professor Ju Sang Kim (right) and Korean colleagues